Ethyldeshydroxy-sparsomycin (EdSm) is a rlbosomal pro tein synthesis Inhibitor which synerglstically enhances the antitumor activity of cisplatin against L.1210 leukemia In vivo. Because cellular glutathione (GSH) and glutathione Stransferases (GST) are reported to interfere with the antitumor activity of cisplatin, we analyzed the effect of EdSm and cisplatin on GSH and GST activity in selected tumor cells. For this purpose we used three murine leukemia tumors with different sensitivities towards EdSm and cisplatin: L1210-WT, sensitive to both drugs, L1210-Sm, resistant to EdSm, and L1210-CDDP, resistant to cisplatin. No significant differences were detectable between these three cell lines regarding the population doubling time, the cell size, and the cellular level of protein and glutathione. Neither of the resistant L1210 subclones showed P-glycoprotein expression. Drug exposure, however, changed the Intracellular dynamics. Exposure to EdSm strongly de creased the amount of cellular protein, decreased the overall GST activity and led to GSH depletion, whereas exposure to cisplatin induced a rise in the amount of protein, in GSH, and In the total GST activity. These effects are dose-dependent and correlate well with the sensitivity of the tumor cells for EdSm or cisplatin. In addition, exposure to EdSm lowered the of GST in L121Q-WT and L1210-Sm; however, In L1210-CDDP both the Vm QX and the Km were Increased. That this was not a direct effect of EdSm on GST was shown in a cell-free system, where EdSm did not Influence the GST activity nor could It act as a substrate for GST. Our results suggest that the synergis tic combination of EdSm and cisplatin might be explained by EdSm switching off the cellular detoxification mechan ism for cisplatin, i.e. by Inhibition of de novo synthesis and subsequent depletion of GSH and GST.
Introduction
This .study was supported by a Grunt of the Dutch Cancer Society, by Pharmachemie IiV, The Netherlands, and by the Maurlts and Ethyldeshydroxy-sparsomycin (EdSm) is a potent inhibitor of ribosomal protein synthesis1 and is one of the sparsomycin analogs which show enhanced antitumor activity in comparison to sparsomycin.2 In addition» EdSm synergistically enhances the anti tumor activity of cisplatin In vivo in mice bearing LI 210 leukemia tumor cells sensitive to both drugs3 but is unable to do so w hen these tumor cells are resistant to one of these drugs/1 The in vitro sensitivity of LI 210 leukemia cells correlates well with the antitumor activity of EdSm and cisplatin in vivo, The cellular factors of these leukemic tumors, which are responsible for the enhanced chemosensitivity to combined drug treatment, are unknown. Likewise, it is not known for these leukemic cell lines w hich mechanism is* involved in cisplatin resistance or EdSm resistance.
Glutathione, a tripeptide containing a sulfhydryl group, protects cells from oxidative damage, partici pates in the transport of amino acids, and is a cofactor for ribonucleotide reductase, which is required for deoxyribonucleotide synthesis. Gluta thione conjugation, established by a family of glutathione-S-transferases (GSTs), provides a defense mechanism because it removes potentially toxic lowsoluble and/or eleetrophilic compounds by convert ing them into better water-soluble and non-electrophilic conjugates, A logical but undesirable effect of glutathione therefore is its potential involvement in cellular resistance after long or repeated exposure to anticancer agents. Tumor cells may adapt to chemi cal or nutritional depletion of GSH by producing a rebound elevation of GSH levels and the induction of elevated levels of specific GST iso-forms. Cellular concentrations are maintained by cle novo synthesis of GSH from the constituent amino acids, using the enzymes r-glutamyl cysteine synthetase and glu tathione synthetases. A number of reports describe months, an elevated level of glutathione in tumor cells, which are resistant to cisplatin,5 ~8 but a decreased cisplatin HP Hofs e t al.
are stably resistant in drug-free media for up to 6 uptake 9. 10 and increased DNÀ repair have been Drugs reported as well, resulting in less DNÀ interstrand 11 -13 Moreover, the activity of GST in EdSm was synthesized at the Department of Organic cross-links. cisplatin-resistant tum or cells is often increased com pared to cisplatin-sensitive tumor cells.11115 GSH depletion can increase the chemosensitivity to 5 ( 16_'IB cisplatin 'v or partially reverse cisplatin resis tance. 19 On the other hand, conflicting results were obtained upon in vivo glutathione depletion using Chemistry (University of Nijmegen, The Nether lands) 1 and was acquired in a lyophilized form. The drug was dissolved in phosphate buffered saline (PBS, pH 7.4) and kept in dark flasks at 4°C. Cisplatin was kindly provided by Pharmachemie (Haarlem, The Netherlands). Solutions with the DL-buthionine sulfoximine (BSO). One report foiled required drug concentration were prepared just to observe an increase of the antitumor activity of before administration by dilution with isotonic NaCl. 20 cisplatin, yet another report showed an increase in sensitivity to cisplatin.1 EdSm, being a potent inhibitor of ribosomal protein synthesis, might in-Drug treatment hibit cle novo synthesis of enzymes like GST and of enzymes needed for glutathione synthesis, thereby
The L1210 leukemia cells were seeded and allowed potentiating the antitumor activity of cisplatin.
to grow in a fresh, drug-free medium for 24 h. In this study w e addressed these questions using Thereafter, EdSm or cisplatin were applied in inthree murine leukemia tumors which show signifi-creasing concentrations from 0.01 to 30 fxM for a cant differences in cytotoxic IC50 levels for EdSm or period of 20 h. To investigate the effect of drug cisplatin, and great differences in antitumor re-exposure on enzyme kinetics of GST the tumor cells sponses. The mechanism responsible for these sensitivity differences is unknown. Therefore, infor mation about cellular changes in tumor cells after were exposed to 30 /¿M EdSm during 4 h. After drug exposure, the tum or cells were washed twice with PBS and used for different assays. The cell viability EdSm exposure could be very valuable in order to was checked by dye exclusion using Trypan blue predict the chemomodulatorial antitumor activity of and the cell numbers were determined using a EdSm in drug combinations and possibly for other hemocytometer. All experiments were performed in protein synthesis inhibitors as well. In an attempt to explain the patterns of synergistical drug interactions in these leukemic murine tumors w e investi gated the dynamics of a panel of cellular parameters: protein content, GSH and GSSG content, and GST activity.
triplicate.
Cytotoxicity assays

Materials and methods
Cell culture
The culture conditions for murine 11210 leukemia cells have been described earlier. 1 The murine LI210 leukemia wild-type (L12I0-WT) and the cis platin-resistant subclone (L1210-CDDP) were kindly supplied by Dr G Atassi (Institute Jules Bordet, Laboratory for Experimental Chemotherapy Brus sels, Belgium). We have established another sub clone of the mouse tumor cell line L1210 with acquired resistance to sparsomycin by repeated in vivo treatment with increasing doses of deshydroxysparsomycin (L1210-Sm). In vitro these subclones The clonogenic ability of drug-treated cells was evaluated by a soft-agar colony assay Leukemic colonies w ere grown by plating the cells in 0.3% agar in six-well plates (Costar) in a drug-free med ium. After 8 days of incubation, colonies (greater than 50 cells) w ere scored using an inverted micro scope. The surviving fraction was calculated by dividing the absolute survival (number of colonies) of the treated sample by the absolute survival of a parallel control sample. Each experimental point was determined in duplicate and all experiments were repeated twice.
Flow cytometry
Cell cycle distributions, Single-celi preparations were obtained from control cultures and lixed in
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Effects of ethyldvsh)ulrox)'sparso/fryein on CrSH a n d GS7 ì f i/ïrt 70% ethanol. The cells w ere removed from the fixative by centrifugation and washed with PBS, The stained in 400 u\ PBS containing nated ceil liomogenates with the lluorometric method of Hissin and Hilf using o-phthalaldehyde. were G ST 20 fig/m l propidium iodide and were measured with a flow cy tome ter 5 OH (Ortho Instruments, Weatwood, CA). Red fluorescence, for DNA content measurement, was detected through a 630 nm long GST catalyses the transfer of the -SI I group of pass filter and photomultiplier pulses were amplified glutathione to specific substrates. The activities of linearly.
GSH transferases were measured at 25°C spectrophotometrieally with L-chloro-2,4-din it mbenzene (CDNB) as a substrate according to the procedure of 1 The conjugate, GDNB -glutathione, has an P-glycoprotefn (Pgp)-For flow-cytometric analysis of Pgp expression, tumor cells were labeled with the Pgp-specific monoclonal antibody MRK16 (a gift absorbance band at 340 nm and the activity of the enzyme can therefore be estimated by measuring the from Professor T Tsuruo) according to the method of Haniada/ 1 Thereafter, cells were stained with fluoresceinated rabbit anti-mouse IgG (Dakopatts, Glostrup, Denmark), FITC-"RAM~F(ab')2 fragments 1:50 diluted in PBS. Cells stained with FITC were kinetics of the change in optical density at this wavelength, Assays were performed in 100 mM potassium phosphate, pH 7.4, 1 mM EDTA, 5 mM GSH, 1 mM CDNB and 0,1 mg/ml cytosolic protein, analyzed by flow cytometry using a 515/530 band-Michaelis-Menten kinetics of cytosolic GSH trans pass filter. The area of the green fluorescence signal and both area and peak value of the red fluorescence signal were recorded in list mode and analyzed with a PDP11/34 computer (Digital Equipment, Galway, Ireland). ferases of sonicated cells were measured using CDNB as a substrate. GSH concentrations in the assay system were fixed at 1 mM. The Km and were calculated using the Lineweaver-Burk plot.
Cell size, Flow cytometry of the samples was done with a cytofluorograph equipped with on-line com puter analysis. The exact relationship between
Statistics scattered light and cell size is difficult to quantify. It depends on the light collection, angle, aperture and index of refraction of the suspending fluid. Usually, however, the scattered light increases mono ton ically with the cell volume. In this study, latex micro spheres of 10 and 20 ftm w ere used to calibrate any differences in cell size between these three cell lines, All samples were light-mieroscopically checked for differences in size.
A comparison of the different sample distribution is usually performed on the log-scale in order to reduce skewness, be more robust against outliers or make the SDs more comparable, liven if this transforma tion to the log-scale seems unnecessary-as in this study-there is hardly any harm in doing so. Differences between the means of different groups were compared using the analysis of variance (ANOVA) in combination with the Ryan multiple /•test. All computations were done by SAS, proc, ANOVA. The results have been expressed as the mean ± SE and p < 0,05 was considered to be significant, Protein
For an estimation of the amount of protein we used the lluorometric assay of lldenfriend/ 2 as modified by Lai/* Bovine serum albumin was used for calibration.
Results
Biological characteristics of the L1210 leukemia cell lines Glutathione
Glutathione consists of two forms, reduced (GSH) and oxidized (GSSG), and can be determined by established enzymatic techniques/ 1 Cellular glutathione content was determined from the deprotei-IC50 levels of the various cell lines for EdSm and cisplatin are compiled in Table 1 . The cisplatinresistant L1210 line (LI 210-01)DP) acquired some resistance to EdSm as well, resulting in a resistance factor of 4 compared to 18 in 1,121O-Sm. Yet, the L'1210-Sm has normal sensitivity for cisplatin. No detectable, significant difference was found between CIC50 is the drug concentration needed during an exposure time of 20 h to give 50% growth inhibition in a colony-forming assay. dRF is the resistance factor, representing the fold increase in IC5o for a specific drug in a resistant cell line relative to the wild-type.
the three cell lines regarding population doubling phase cells is signiiicantly higher than that of LI2 10times, cell diameter and Pgp expression. Only the vSm cells, values which are 62.3 and 49.4%, respeccisplatin-resistant cell population harbors a few posi-tively. Moreover, the percentage of L1210-CDDP cells live cells (2.2%). However, the intensity of their (6.8%) in the G2M phase is low compared to these fluorescence was low as a consequence of which values of L1210-WT (11,6%) and LJ210-Sm (12.7%) we ignored this information. Whilst the population cells. The percentage of Gi phase cells is not doubling time is the same for all three cell lines, the significantly different within the three cell lines, analysis of the cell phase distribution during expo-Furthermore, no difference was found in the average nential growth (Table 2 ) revealed significant differ-protein content of these cell lines ( Table 3 ). The ences (p = 0 .03) with respect to the number of average glutathione levels in the resistant cell lines cells in the S phase. To be more specific, the also did not change significantly: p = 0.35 for GSH percentage of L1210-CDDP tumor cells in the S oxidized, p = 0.48 for GSSG and p -0.32 for total Hffects o f eth yldeshydroxysparsotnycïn on GSH and GST glutathione ( Table 3) . Moreover, a 2:1 molar ratio between GSH and GSSG was found in all cell lines. drug treatment with cisplatin or EdSm and the 100% control level were statistically analyzed. The curves The specific GST activities are different ( Table 3 ). In of L1210-WT and L1210-CDDP are significantly differparticular, if we compare the L1210-Sm with the ent, p ~ 0.04 and 0.05, respectively Worth mention-L1210-CDDP cell line, we notice an elevated level of ing is the situation in L1210-Sm, in which EdSm 58 versus 38.2 nm ol/m in/m g protein, respectively exposure only caused a moderate effect, while (ƒ> = 0.04), or 2.36 and 1.84 nm ol/m in/106 cells, cisplatin had no effect at all (ƒ)== 0.45). Comparable respectively (/; = 0,09). effects w ere observed for GST activity, Because we are interested in the total effect per tumor cell, we decided to express the values for the glutathione level and GST activity in units per 10° cells instead of mg protein. The effect of both drugs on the overall cellular GST activity is represented in Figure  2 . These results parallel the effects observed for the The dose-eflect curves for cisplatin and EdSm intracellular protein level, but significant differences diverge in all three cell lines. Inhibition of the between EdSm and cisplatin were found only in the protein synthesis by EdSm has a strong impact on L1210-WT cell line (/> = 0.0i), while the effect in
Effects of EdSm and cisplatin on the intracellular protein and glutathione levels and on the G ST activity the cellular protein content (Figure 1 ). EdSm causes the L1210-CDDP cell line conies close to significance a dose-dependent decrease in protein level, which is (p = 0,06). Thus, the decrease in GST activity (when most extensive and most rapid in LI210-WT, and treated with EdSm) parallels the decrease in total already starts at submicromolar EdSm eoncentra-protein. Similarly the increase in GST activity (when tions. This decrease is more gradual in L1210-CDDE treated with cisplatin) follows the increase in p ro L1210-Sm is clearly less sensitive and requires at tein content. This implies that if the specific activity least 10 ¿¿M to see the same effect. Cisplatin causes of GST was expressed in nm ol/m in/m g protein, no the opposite effect, i.e. a dose-dependent increase in significant differences are found in these cell lines protein level in the L1210-CDDP and L1210-WT cell neither between EdSm and cisplatin treatment, nor lines with little effect on L1210-Sm. The curves of between drug-treated and control cells. 
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Effects of EdSm and cisplatin on the intracellular glutathione dynamics HP Hofs e t a l Figure 3 shows the results of drug treatment on the intracellular glutathione level in these leukemic tumors. Again, EdSm and cisplatin showed opposite effects in these three cell lines, and again these effects are dose-and cell line-dependent. Significant differences have only been observed in the L1210-WT cell line (p -0.05). Only about 3 /¿M was required to induce strong GSH depletion in L121.0-WT. In the sp a rsomyc in-resist ant tumor 3 /iM EdSm evoked a 50% increase in GSH level and a significant decrease was only observed at 30 ¡ttM. In the cisplatin-resistant tumor the GSH depletion dropped with EdSm by 3 /¿M or greater, albeit slowly com pared to the wild-type. The effect of cisplatin treatment on the GSH levels followed the same pattern as seen w ith GST and protein.
Enzyme kinetics
First we investigated w hether EdSm and cisplatin could directly affect the activity of GST or the assay.
The results in a cell-free system (Table 4) lower value, but we do not know whether this is due to inhibition of the enzyme, a low substrate potential or interference with the assay (e.g. reaction with GSH, CDNB or the product). We did not pursue this any further since, under our standard conditions (30 ftM or lower), no effect was observed and the intracellular-free concentrations of CDNB will cer tainly not reach the 10 mM level. The next question we addressed was whether EdSm could interfere with intracellular GSH transferases. We therefore used the Michaelis-Menten kinetics to estimate the K,1 1 U X and Km of cellular GST in the presence of 30 ¿iM EdSm for a period of 4 h. These results are summarized in Table 5 . In the control situation we saw a significant difference in VnvAX between LI 210-CDDP (150 nmol/min/mg protein) and the other cell lines, .LI 210-WT (107 nm ol/m in/m g protein) and L1210-Sm (95 nm ol/m in/m g protein). This is even more pronounced for the Km values. The Km value for CDNB in the IJ210-CDDP cell line is almost 3"loId higher than that of LI 210-WT and L1210-Sm. Exposure to EdSm reduced the maximal activity on a protein base in L1210-WT and L1210-Sm, although not significantly, and increased the Vtmx in L1210-CDDP cell lines. These EdSm effects, however, were not significant, which is in part due to the small sample number.
Discussion
At the onset of our study no information was available about the mechanisms underlying resis tance against cisplatin in L1210-CDDP and against EdSm in LI 210-Sin. Our results show ( Table 1 ) that these three leukemic tumor cell lines are compar able as to the population doubling time and cell size. Also, the protein content and total glutathione level are similar in these cell lines ( Table 3 ). The GST Table 4 ). Exposure of intact tumor cells to EdSm yielded a four gene families: the a, /t, n and 0 class. The n-dose-and cell line-dependent decline in cellular class is preferentially expressed in tumor cells. They protein content, glutathione level, as well as in the function as dimers, with heterodimers occurring in total GST activity. This dose-dependency of the 2o the same class. The various classes have different decline in protein content in the individual cell lines specific activities and different substrate specificity.
upon EdSm treatment correlates directly with the We have measured the overall cellular GST pool and the differences we observed between the cell lines most likely indicate a substantial variation at the isoenzyme level. Another difference between these cell lines was detected in the cell phase distribution. L1210-CDDP cells contain more S phase cells and less G2M cells than L1210-WT and. L1210-Sm, which indicates a prolonged S phase, probably due to enhanced DNA repair. Another parameter often involved in resistance to chemotherapy is the elevated expression of a Pgp of 170 kDa, which acts as a broad spectrum membrane pump and removes which could cause effects such as depletion of GSH sensitivity of each cell line for EdSm! Under normal conditions the cellular level of a protein is deter mined by the balance between the rates of its synthesis and degradation. The average turnover times for individual proteins range from several minutes to months or even years/ 2 Many intracellu lar proteins that have half-lives of 10 min or less are proteins with key regulatory roles whose cellular level is rapidly regulated by modulating their rate of synthesis." Inhibition of protein synthesis by EdSm will directly disturb short-lived protein balance, chemotherapeutic drugs as well. Although Pgp ex and GST. The cellular glutathione level is maintained pression has never been implied in cisplatin resis-by de novo synthesis of GSH from the constituent tanec, other antitumor agents have been shown to be able to induce Pgp expression in murine leuke mic cells.30 Even alkylating agents, like mitomycin C, can induce resistance in L'l 210 leukemia cells through changes in the membrane Pgp population/ 1 but these tumor cells remain sensitive to cisplatin. A possible Pgp induction by Sm derivatives has not yet amino acids, using the enzymes r-glulamyl cysteine synthetase and glutathione synthetase. Furthermore, glutathione cycles between a reduced thiol form (GSI1) and an oxidized form (GSSG) in which two GSH tripeptides are linked by a disulfide bond, and these enzymes w hich also implicates that these Acknowledgments enzymes have relatively short turnover times and HP Hofs e t al.
require a high level of de m w o synthesis.
The antibody MRK16 was kindly supplied by Profes-In combined chemotherapy we must be cautious sor TTsuruo, University of Tokyo, Japan. not to interpret many of the effects as the result of simple direct interaction between cytostatic agents. As this study has also shown, administration of cisplatin can cause the induction of endogenous GSH synthesis, as well as enhanced levels of enzymes such as GST which can catalyze the detoxification of agents such as cisplatin.35 GSH depletion by BSO suggests two roles for GSH in cisplatin resistance, i.e. cytosolic elimination, result ing in less DNA platination, and a nuclear effect on the formation and repair of DNA platinum adducts; Cisplatin can also conjugate non-enzymatic with sulfhydryl compounds like glutathione;
This reaction involves nucleophilic displacement of chlor ide ligands, either directly or subsequent to a reaction with water. This type of reaction could explain the apparent reduction in GST activity that we observe at very high cisplatin concentrations. In addition to GSH, other thiols, like the metallothioneins (MT), can act as a nucleophile towards electrophilic agents like cisplatin, but the involve ment of MT in acquired resistance to cisplatin is rather controversial. " "
In the murine leukemia cell line L121Q, the degree of resistance was reported to be associated with the level of MT;9 however, in another study the resistance of LI 210-CDDP cell towards cisplatin could neither be based on an increased level of MT nor on an enhanced ability to increase the synthesis of MT after cisplatin exposure.11 Thus, MT may be associated with the induction of cisplatin resistance, but its causal role remains to be established. It should be noted that resistance to cisplatin is a relative term, which is at least partially attributable to its narrow therapeutic index. Because of fatal toxicity, it is often not possible to successfully treat tumors, which exhibit even a small inherent resistance to cisplatin, by increasing the dose level of cisplatin, As a conse quence, combination therapy with an agent like EdSm, which enhances cisplatin's anti tumor effects with little or no enhancement of cisplatin's toxicity/ ' may be of value in the treatment of tumors which resist treatment with cisplatin alone.
To summarize, our results suggest that the syner gistic combination of EdSm and cisplatin can, at least partly, be explained by the EdSm-induced block of protein synthesis, with subsequent depletion of the cellular detoxification mechanism for cisplatin, and will very likely Involve a reduction in the intracellu lar level of GSH.
